SG/PUT/DERMAPHARM HOLDING/30/0.1/20.12.24 Share Price

Warrant

DE000SU9LJM7

Market Closed - Börse Stuttgart 07:10:34 25/06/2024 BST
0.13 EUR -7.14% Intraday chart for SG/PUT/DERMAPHARM HOLDING/30/0.1/20.12.24
Current month-18.75%
1 month-7.14%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
25/06/24 0.13 -7.14%
24/06/24 0.14 0.00%
21/06/24 0.14 0.00%
20/06/24 0.14 -6.67%
19/06/24 0.15 +7.14%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 07:10 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SU9LJM
ISINDE000SU9LJM7
Date issued 20/02/2024
Strike 30
Maturity 20/12/2024 (178 Days)
Parity 10 : 1
Emission price 0.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.11
Delta-0.22x
Omega 5.481
Premium20.03x
Gearing24.62x
Moneyness 0.8403
Difference Strike -5.7
Difference Strike %-19.00%
Spread 0.01
Spread %6.67%
Theoretical value 0.1450
Implied Volatility 39.14 %
Total Loss Probability 68.18 %
Intrinsic value 0.000000
Present value 0.1450
Break even 28.55 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
35.7 EUR
Average target price
50.12 EUR
Spread / Average Target
+40.41%
Consensus